Now in our 13th year of bringing you beautiful imagery from biomedical science every day

Search the archive of over 4000 images

Relapse after immunotherapy for cancer explained by tumour cells hiding within other cells so avoiding destruction

14 October 2022

Attacks Evaders

Cancer cells are masters of evasion, finding innovative ways to survive treatments. Researchers now investigate why tumours return after immunotherapy, a treatment using the immune system’s killer T-cells which appear to effectively target and then kill cancer cells by injecting them with toxic granules. In a mouse cancer model, where tumours have returned after initial immunotherapy, scanning electron microscopy revealed that cancer cells hid within each other – a process called cell-in-cell formation – to avoid destruction. Exposing cancer cells from the tumours, to different immune cells in a dish revealed that killer T-cells specifically triggered cell-in-cell formation, as captured here using live-cell imaging. Injecting mice with drugs that blocked a molecular pathway activated by the killer T-cell attack before cell-in-cell formation, increased the effectiveness of subsequent immunotherapy. This reveals an important cancer mechanism for evading immunotherapy and a starting point to counter it.

Written by Lux Fatimathas

Search The Archive

Submit An Image

Follow on Tumblr

Follow on Instagram

What is BPoD?

BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.

Read More

BPoD is also available in Catalan at with translations by the University of Valencia.